Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer.
Tempest Therapeutics stock last closed at $0.76, down 3.7% from the previous day, and has decreased 92.39% in one year. It has underperformed other stocks in the Biotechnology industry by 0.76 percentage points. Tempest Therapeutics stock is currently +1.62% from its 52-week low of $0.74, and -93.83% from its 52-week high of $12.23.
As of Sep 15, 2026, there are 15.98M shares of TPST outstanding. The market capitalization of TPST is $12.06M. In the past 24 hours, 8.6M TPST shares were traded.
You need an online brokerage account to access the NASDAQ market and buy TPST shares.
In our opinion, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you'll need to fill out some personal info so you can invest in TPST stock today.
Now that you've created your account on a good online stock trading app, you need to deposit funds:
Check out the tutorial below if you need help transferring funds into your brokerage account.
Once you have identified the best place to buy Tempest Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can view all of the due diligence checks on TPST's stock page.
You can use many financial metrics, analyses, models, and charts to gauge TPST's fair value.
You can do additional valuation research on TPST's stock here.
You can dig deeper into what analysts are forecasting on the Tempest Therapeutics stock forecast page.
In the last year, insiders at TPST have bought more shares than they have sold.
Matthew Angel, CEO and President of TPST, was the latest TPST insider to buy. They bought $500,001.12 worth of TPST shares on Mar 24, 2026.
Dig into more about who owns TPST shares here.
No, Tempest Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main options:
Press the Open Trade button and eToro will place your order.
If you need more assistance investing in stocks on eToro, click the helpful video below:
Now that you own some TPST stock, you'll want to stay up-to-date on your new company.
Put TPST on a watchlist to keep track of your TPST stock.
To reiterate, here are the 6 steps to buy Tempest Therapeutics stock:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your investment in Tempest Therapeutics, get started below.